当前位置: X-MOL 学术Cancer Cell › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Cancer vaccines
Cancer Cell ( IF 48.8 ) Pub Date : 2022-06-13 , DOI: 10.1016/j.ccell.2022.05.015
John T. Schiller , Douglas R. Lowy , Ian H. Frazer , Olivera J. Finn , Eduardo Vilar , H. Kim Lyerly , Sacha Gnjatic , Neeha Zaidi , Patrick A. Ott , Vinod P. Balachandran , Pierre-Yves Dietrich , Denis Migliorini , Robert H. Vonderheide , Susan M. Domchek

Given the renewed interest in vaccine development sparked by the COVID-19 pandemic, we are revisiting the current state of vaccine development for cancer prevention and treatment. Experts discuss different vaccine types, their antigens and modes of action, and where we stand on their clinical development, plus the challenges we need to overcome for their broad implementation.



中文翻译:

 癌症疫苗


鉴于 COVID-19 大流行引发了人们对疫苗开发的新兴趣,我们正在重新审视癌症预防和治疗疫苗开发的现状。专家们讨论了不同的疫苗类型、它们的抗原和作用方式,以及我们在临床开发方面的立场,以及我们在广泛实施它们时需要克服的挑战。

更新日期:2022-06-13
down
wechat
bug